Correction: Safety and efficacy of sofosbuvir plus ledipasvir with and without ribavirin for chronic HCV genotype-1 infection: a systematic review and meta-analysis
Antivir Ther
.
2017;22(5):457.
doi: 10.3851/IMP3092.
Epub 2016 Sep 22.
Authors
Hussien Ahmed
1
2
3
,
Ahmed Elgebaly
2
4
,
Abdelrahman Ibrahim Abushouk
2
5
6
,
Ali Mohamed Hammad
2
7
,
Attia Attia
2
4
,
Ahmed Negida
1
2
3
8
Affiliations
1
Faculty of Medicine, Zagazig University, Zagazig, Egypt.
2
Medical Research Group of Egypt, Cairo, Egypt.
3
Student Research Unit, Zagazig University, Zagazig, Egypt.
4
Faculty of Medicine, Al-Azhar University, Cairo, Egypt.
5
Faculty of Medicine, Ain Shams University, Cairo, Egypt.
6
NovaMed Medical Research Association, Cairo, Egypt.
7
Faculty of Medicine, Cairo University, Cairo, Egypt.
8
School of Medicine, Liverpool University, Liverpool, UK.
PMID:
27658518
DOI:
10.3851/IMP3092
No abstract available
Publication types
Published Erratum